Aquaculture Vaccines Market Size & Share Report, 2034

Aquaculture Vaccines Market – By Vaccine Type, By Route of Administration, By Application, By Species – Global Forecast, 2025 – 2034

Report Content

Chapter 1&nbsp;&nbsp;&nbsp;Methodology and Scope

1.1&nbsp;&nbsp;&nbsp; Market scope and definition

1.2&nbsp;&nbsp;&nbsp; Research design

1.2.1&nbsp;&nbsp;&nbsp; Research approach

1.2.2&nbsp;&nbsp;&nbsp; Data collection methods

1.3&nbsp;&nbsp;&nbsp; Base estimates and calculations

1.3.1&nbsp;&nbsp;&nbsp; Base year calculation

1.3.2&nbsp;&nbsp;&nbsp; Key trends for market estimation

1.4&nbsp;&nbsp;&nbsp; Forecast model

1.5&nbsp;&nbsp;&nbsp; Primary research and validation

1.5.1&nbsp;&nbsp;&nbsp; Primary sources

1.5.2&nbsp;&nbsp;&nbsp; Data mining sources

Chapter 2&nbsp;&nbsp;&nbsp;Executive Summary

2.1&nbsp;&nbsp;&nbsp; Industry 3600&nbsp;synopsis

Chapter 3&nbsp;&nbsp;&nbsp;Industry Insights

3.1&nbsp;&nbsp;&nbsp; Industry ecosystem analysis

3.2&nbsp;&nbsp;&nbsp; Industry impact forces

3.2.1&nbsp;&nbsp;&nbsp; Growth drivers

3.2.1.1&nbsp;&nbsp;&nbsp;Surging prevalence of bacterial and viral infections

3.2.1.2&nbsp;&nbsp;&nbsp;Increasing aquaculture production across the globe

3.2.1.3&nbsp;&nbsp;&nbsp;Development and launch of new aquaculture vaccines

3.2.1.4&nbsp;&nbsp;&nbsp;Rising adoption of aquaculture vaccines over antibiotics

3.2.2&nbsp;&nbsp;&nbsp; Industry pitfalls and challenges

3.2.2.1&nbsp;&nbsp;&nbsp;Stringent regulatory policies for vaccine approval

3.2.2.2&nbsp;&nbsp;&nbsp;Complex vaccine development procedures

3.3&nbsp;&nbsp;&nbsp; Growth potential analysis

3.4&nbsp;&nbsp;&nbsp; Regulatory landscape

3.5&nbsp;&nbsp;&nbsp; Pipeline analysis

3.6&nbsp;&nbsp;&nbsp; Future market trends

3.7&nbsp;&nbsp;&nbsp; Porter&rsquo;s analysis

3.8&nbsp;&nbsp;&nbsp; PESTEL analysis

Chapter 4&nbsp;&nbsp;&nbsp;Competitive Landscape, 2024

4.1&nbsp;&nbsp;&nbsp; Introduction

4.2&nbsp;&nbsp;&nbsp; Company market share analysis

4.3&nbsp;&nbsp;&nbsp; Company matrix analysis

4.4&nbsp;&nbsp;&nbsp; Competitive analysis of major market players

4.5&nbsp;&nbsp;&nbsp; Competitive positioning matrix

4.6&nbsp;&nbsp;&nbsp; Strategy dashboard

Chapter 5&nbsp;&nbsp;&nbsp;Market Estimates and Forecast, By Vaccine Type, 2021 &ndash; 2034 ($ Mn)

5.1&nbsp;&nbsp;&nbsp; Key trends

5.2&nbsp;&nbsp;&nbsp; Inactivated vaccine

5.3&nbsp;&nbsp;&nbsp; Live attenuated vaccine

5.4&nbsp;&nbsp;&nbsp; Subunit vaccine

5.5&nbsp;&nbsp;&nbsp; Other vaccine types

Chapter 6&nbsp;&nbsp;&nbsp;Market Estimates and Forecast, By Route of Administration, 2021 &ndash; 2034 ($ Mn)

6.1&nbsp;&nbsp;&nbsp; Key trends

6.2&nbsp;&nbsp;&nbsp; Injection vaccines

6.3&nbsp;&nbsp;&nbsp; Immersion and spray

6.4&nbsp;&nbsp;&nbsp; Oral vaccines

Chapter 7&nbsp;&nbsp;&nbsp;Market Estimates and Forecast, By Application, 2021 &ndash; 2034 ($ Mn)

7.1&nbsp;&nbsp;&nbsp; Key trends

7.2&nbsp;&nbsp;&nbsp; Bacterial

7.3&nbsp;&nbsp;&nbsp; Viral

7.4&nbsp;&nbsp;&nbsp; Parasitic

7.5&nbsp;&nbsp;&nbsp; Combined

Chapter 8&nbsp;&nbsp;&nbsp;Market Estimates and Forecast, By Species, 2021 &ndash; 2034 ($ Mn)

8.1&nbsp;&nbsp;&nbsp; Key trends

8.2&nbsp;&nbsp;&nbsp; Salmon

8.3&nbsp;&nbsp;&nbsp; Trout

8.4&nbsp;&nbsp;&nbsp; Tilapia

8.5&nbsp;&nbsp;&nbsp; Seabass

8.6&nbsp;&nbsp;&nbsp; Seabream

8.7&nbsp;&nbsp;&nbsp; Turbot

8.8&nbsp;&nbsp;&nbsp; Carp

8.9&nbsp;&nbsp;&nbsp; Other species

Chapter 9&nbsp;&nbsp;&nbsp;Market Estimates and Forecast, By Region, 2021 &ndash; 2034 ($ Mn)

9.1&nbsp;&nbsp;&nbsp; Key trends

9.2&nbsp;&nbsp;&nbsp; North America

9.2.1&nbsp;&nbsp;&nbsp; U.S.

9.2.2&nbsp;&nbsp;&nbsp; Canada

9.3&nbsp;&nbsp;&nbsp; Europe

9.3.1&nbsp;&nbsp;&nbsp; Germany

9.3.2&nbsp;&nbsp;&nbsp; UK

9.3.3&nbsp;&nbsp;&nbsp; France

9.3.4&nbsp;&nbsp;&nbsp; Spain

9.3.5&nbsp;&nbsp;&nbsp; Italy

9.3.6&nbsp;&nbsp;&nbsp; Norway

9.3.7&nbsp;&nbsp;&nbsp; Ireland

9.3.8&nbsp;&nbsp;&nbsp; Turkey

9.3.9&nbsp;&nbsp;&nbsp; Denmark

9.4&nbsp;&nbsp;&nbsp; Asia Pacific

9.4.1&nbsp;&nbsp;&nbsp; China

9.4.2&nbsp;&nbsp;&nbsp; India

9.4.3&nbsp;&nbsp;&nbsp; Indonesia

9.4.4&nbsp;&nbsp;&nbsp; Philippines

9.4.5&nbsp;&nbsp;&nbsp; Thailand

9.4.6&nbsp;&nbsp;&nbsp; Vietnam

9.4.7&nbsp;&nbsp;&nbsp; Australia

9.4.8&nbsp;&nbsp;&nbsp; New Zealand

9.5&nbsp;&nbsp;&nbsp; Latin America

9.5.1&nbsp;&nbsp;&nbsp; Brazil

9.5.2&nbsp;&nbsp;&nbsp; Mexico

9.5.3&nbsp;&nbsp;&nbsp; Chile

9.6&nbsp;&nbsp;&nbsp; Middle East and Africa

9.6.1&nbsp;&nbsp;&nbsp; Iran

9.6.2&nbsp;&nbsp;&nbsp; Egypt

Chapter 10&nbsp;&nbsp;&nbsp;Company Profiles

10.1&nbsp;&nbsp;&nbsp; CIBA

10.2&nbsp;&nbsp;&nbsp; HIPRA

10.3&nbsp;&nbsp;&nbsp; Kyoto Biken Laboratories

10.4&nbsp;&nbsp;&nbsp; Kemin Industries

10.5&nbsp;&nbsp;&nbsp; Kyoritsuseiyaku Corporation

10.6&nbsp;&nbsp;&nbsp; Merck Animal Health (Merck &amp; Co.)

10.7&nbsp;&nbsp;&nbsp; Nisseiken

10.8&nbsp;&nbsp;&nbsp; Phibro Animal Health Corporation

10.9&nbsp;&nbsp;&nbsp; Tecnovax

10.10&nbsp;&nbsp;&nbsp; Virbac

10.11&nbsp;&nbsp;&nbsp; Veterquimica

10.12&nbsp;&nbsp;&nbsp; Vaxxinova International

10.13&nbsp;&nbsp;&nbsp; Zoetis 
&nbsp;

Aquaculture Vaccines Market

Inquiry Before Buying